Ind-Swift Laboratories (INDSWFTLAB) Share Price Falls 9.08% in Latest Session
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Ind-Swift Laboratories Share Price is under pressure in the latest trade, with the stock at Rs 376.10, down 9.08% from the previous close. According to Univest data, the company’s market capitalisation stands at Rs 3,550.64 Cr, placing Ind-Swift Laboratories in the Small Cap category. The move is relevant because it was a sharp same-day price fall, yet the verified data does not establish a company-specific catalyst. For readers tracking Ind-Swift Laboratories Share Price Today, the main question is whether the decline is only a market repricing of the stock or whether the current valuation and sector comparison help explain the weakness. As of 30 September 2026 at 3:33:26 PM IST, the latest Univest figures show a clear slide in Ind-Swift Laboratories Share Price, with the stock attracting attention through stock news, price action and fundamental analysis.
Ind-Swift Laboratories (INDSWFTLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 376.1 |
| Previous Close | Rs 413.65 |
| Today's Move | -Rs 37.55 (-9.08%) |
| Open | Rs 415 |
| High | Rs 424.55 |
| Low | Rs 376.1 |
| Market Capitalisation | Rs 3,550.64 crore |
| Market Cap Category | Small Cap |
Ind-Swift Laboratories Share Price Today shows a fall from Rs 413.65 to Rs 376.10, a decline of Rs 37.55 or 9.08%. The stock opened at Rs 415 and moved between Rs 424.55 and Rs 376.10 during the trade, with Rs 376.10 also marking the day’s low. That means Ind-Swift Laboratories Share Price is trading at the lower end of the day’s range after an open above the previous close. The company’s market capitalisation of Rs 3,550.64 Cr keeps it in the Small Cap category. For Ind-Swift Laboratories Share Price News, the important point is straightforward: the latest session recorded a sharp price fall, but according to Univest data, no company-specific catalyst is established. In that setting, the price action itself becomes the main verified signal, and the move is best read alongside valuation, profitability and peer comparison rather than speculation.
The intraday pattern also matters because the stock did not hold the early trade levels. After opening near the previous close, Ind-Swift Laboratories Share Price moved to a session high of Rs 424.55 and then declined to the low of Rs 376.10. Such a sequence often draws attention to how quickly sentiment changed during the day. Here, however, the data stops at the verified market print, so the article remains to the observed decline, the day’s range and the broader financial backdrop. That keeps the focus on confirmed information and avoids any unsupported explanation for the fall.
Ind-Swift Laboratories (INDSWFTLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,550.64 crore |
| P/E Ratio | 62.75x |
| P/B Ratio | 2.56x |
| ROE | 3.47% |
| ROCE | 4% |
| EPS | Rs 6.59 |
| Book Value Per Share | Rs 161.89 |
| Dividend Yield | 0% |
Ind-Swift Laboratories (INDSWFTLAB) fundamental metrics show P/E 62.75x, P/B 2.56x, ROE 3.47%, ROCE 4%. These ratios show where the company stands today and are not a call to buy or sell.
Ind-Swift Laboratories has a market capitalisation of Rs 3,550.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.75x, P/B at 2.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.59, book value per share of Rs 161.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.43x, median ROE of 11.7%, median ROCE of 13.61%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 62.75x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 2.56x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 3.47% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 4% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 3,550.64 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Ind-Swift Laboratories (INDSWFTLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Ind-Swift Laboratories (INDSWFTLAB) has a P/E ratio of 62.75x, which is above the benchmark median of 32.43x, a difference of +93.49%. A P/E difference of this kind is a reference point rather than a recommendation.
Ind-Swift Laboratories (INDSWFTLAB) has a ROE of 3.47%, which is below the benchmark median of 11.7%, a difference of -70.34%. Ind-Swift Laboratories (INDSWFTLAB) has a ROCE of 4%, which is below the benchmark median of 13.61%, a difference of -70.61%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,41,477.63 | 36.9 | 5.16 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
Ind-Swift Laboratories (INDSWFTLAB) has a P/E ratio of 62.75x compared with the displayed peer median of 36.9x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Ind-Swift Laboratories (INDSWFTLAB) has a market capitalisation of Rs 3,550.64 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Ind-Swift Laboratories
- Ind-Swift Laboratories Share Price fell 9.08% in the latest trade, making price action the first point investors notice.
- The stock is in the Small Cap category, with market capitalisation of Rs 3,550.64 Cr.
- Valuation is elevated at a P/E of 62.75 compared with the industry median of 32.43.
- ROE of 3.47% and ROCE of 4% are below the industry benchmark.
- Ind-Swift Laboratories Share Price sits in Healthcare, where peer comparison adds useful context.
About Ind-Swift Laboratories
Ind-Swift Laboratories operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The verified data here identifies the company through sector and industry classification, along with its market capitalisation and listed market metrics. Ind-Swift Laboratories Share Price is therefore linked to a business that belongs to a broad pharmaceutical universe, where valuation and return ratios are often compared closely. The latest Univest figures show the company as a Small Cap with Rs 3,550.64 Cr in market capitalisation. For readers following Ind-Swift Laboratories Stock News, that business context is enough to understand why the stock is being tracked alongside other healthcare names.
Track Ind-Swift Laboratories Share Price on Univest
Use Ind-Swift Laboratories (INDSWFTLAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Ind-Swift Laboratories Share Price on Univest for live price movement, key valuation ratios, market capitalisation, 52-week levels and stock news updates. Univest also helps readers follow Ind-Swift Laboratories Fundamental Analysis, peer context and sector comparison in one place. For investors reviewing Ind-Swift Laboratories Share Price Today, that makes it easier to connect the day’s move with the company’s broader financial profile and industry position.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Ind-Swift Laboratories Share Price fall today?
Ans. Ind-Swift Laboratories Share Price fell 9.08% to Rs 376.10 from Rs 413.65. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as a verified price fall.
What is Ind-Swift Laboratories Share Price Today?
Ans. Ind-Swift Laboratories Share Price Today is Rs 376.10. The stock moved below the previous close of Rs 413.65 after opening at Rs 415, and the latest trade also matched the day’s low of Rs 376.10.
What is Ind-Swift Laboratories market cap?
Ans. Ind-Swift Laboratories has a market capitalisation of Rs 3,550.64 Cr. That places it in the Small Cap category, which is useful context when reviewing Ind-Swift Laboratories Share Price, valuation and peer comparison.
How is Ind-Swift Laboratories valued?
Ans. Ind-Swift Laboratories Share Price is trading at a P/E of 62.75 and a P/B of 2.56. EPS stands at Rs 6.59 and book value is Rs 161.89 per share, which adds depth to the valuation view.
How do Ind-Swift Laboratories ROE and ROCE look?
Ans. ROE is 3.47% and ROCE is 4%. Both are below the industry benchmark median and average, which is an important part of Ind-Swift Laboratories Fundamental Analysis alongside the current Ind-Swift Laboratories Share Price.
How does Ind-Swift Laboratories compare with healthcare peers?
Ans. Compared with peers like Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals and Zydus Lifesciences, Ind-Swift Laboratories Share Price reflects a smaller market cap and weaker return ratios. Its P/E is higher than some peers and lower than others.
Does Ind-Swift Laboratories pay dividend?
Ans. The dividend yield is 0% in the latest figures. That means Ind-Swift Laboratories Share Price is not currently supported by a stated dividend yield, so valuation and earnings quality matter more in the analysis.
Where can I track Ind-Swift Laboratories Share Price news?
Ans. You can track Ind-Swift Laboratories Share Price on Univest for live updates, market capitalisation, valuation ratios and sector context. That gives a practical way to follow Ind-Swift Laboratories Stock News and price action in one place.
